
    
      Detailed Description

      Criteria for Evaluation: FDA Bioequivalence Criteria

      Statistical Methods: FDA bioequivalence statistical methods

      Outcome: Confidence interval fell within 80-125% therefore met the FDA Bioequivalence
      criteria; no drug related, serious, unexpected adverse events were reported during the study.
    
  